MEDTECH Announces Sale of ROSA Robotic Surgery System in Germany

MONTPELLIER, France, Sept. 21, 2015 (GLOBE NEWSWIRE) — MEDTECH (Euronext, FR0010892950 – ROSA), a company specialized in designing, developing and marketing innovative surgical assistance robots, is pleased to announce a new sale of its ROSA™ robot to Frankfurt University Hospital in Germany.

Frankfurt University Hospital is one of the largest health establishments in Germany with more than 3,000 patients treated for neurological disorders per year. The neurosurgery department is of international renown and offers new approaches for the treatment of brain and spine diseases due to its commitment to equipping its patient care unit with the latest technology.

Bertin Nahum, CEO and Founder of Medtech said, “Our recent entry into the German market is bearing its fruits as highlighted by this third ROSA system sale. There continues to be strong momentum in our global business and we are pleased with the acceleration in ROSA™ robot adoptions in Germany, Europe’s No.1 market for medical equipment.” 


Founded in 2002 by Bertin NAHUM and based near Montpellier, MEDTECH is a European specialist in the design, development and marketing of innovative robotic appliances to assist surgeons during their medico-surgical interventions, thus contributing to the implementation of safer, more efficient, less-invasive treatment.

In 2007, MEDTECH developed ROSA™, an innovative technological device devoted to brain surgery procedures. ROSA™ has been approved in Europe, the United States and Canada.

In 2013 Medtech received the “European Company of the Year Award” in the “robotic neurosurgery” category from Frost & Sullivan.

In July 2014, MEDTECH obtained the CE marking for its new product ROSA™ Spine, a robotic- assistive device for minimally invasive surgery of the spine.

In October 2014, MEDTECH won the “Révélation” prize in the Mediterranean Deloitte Technology Fast 50 Awards.

– See more at:

Related Articles

Back to top button